ArticleCell death & disease2022

MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma.

Jinrong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.